A Study to Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab

NCT04205175 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A With Inhibitor

Interventions

DRUG: Feiba

Sponsor

Children's Hospital Los Angeles

Collaborators

[object Object]